scholarly article | Q13442814 |
P2093 | author name string | Z. Reggiardo | |
P2860 | cites work | Immune Response to Sheep Red Blood Cells in Mice Pretreated with Mycobacterial Fractions | Q34174539 |
Acute Granulomatous Response Produced in Mice by Trehalose-6,6-Dimycolate | Q34225185 | ||
Adjuvant effect of cord factor, a mycobacterial lipid | Q34389974 | ||
Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3 | Q34422829 | ||
Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. | Q34504060 | ||
Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets | Q39366662 | ||
BCG and cancer (first of two parts). | Q39900917 | ||
Tumor regression caused by endotoxins and mycobacterial fractions | Q39969179 | ||
Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG | Q40882425 | ||
Stimulation of macrophages by cord factor and by heat-killed and living BCG | Q40908780 | ||
Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin | Q43635137 | ||
Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis | Q44411839 | ||
Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin | Q44703584 | ||
Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse | Q45223474 | ||
Monitoring immunotherapy with serologically active glycolipid fractions of BCG. | Q45256328 | ||
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. | Q46700349 | ||
Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera | Q47936582 | ||
Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma. | Q54019684 | ||
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. | Q54035077 | ||
Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate) | Q68215213 | ||
Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant | Q68580051 | ||
Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes | Q68600595 | ||
Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma | Q68676400 | ||
Serologically active glycolipid families from Mycobacterium bovis BCG. I. Extraction, purification and immunologic studies | Q69364499 | ||
[Effect of inoculation with Calmette-Guerin bacillus on the development of Ehrlich ascites tumor in the mouse.] | Q79161530 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microbiology | Q7193 |
immunology | Q101929 | ||
Mycobacterium bovis | Q133447 | ||
P304 | page(s) | 914-917 | |
P577 | publication date | 1978-09-01 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Antitumor activity of mycobacterial glycolipid A1 | |
P478 | volume | 21 |
Search more.